**Author Information** An event is serious (based on the ICH definition) when the patient outcome is:\* death\* life-threatening\* hospitalisation\* disability\* congenital anomaly\* other medically important event

In an observational comparative study of 181 patients with coronavirus disease 2019 (COVID-19) pneumonia who require oxygen and were admitted to four French tertiary care centres between 12 March 2020 and 31 March 2020, three patients \[*ages and sexes not stated*\] were described, who developed a corrected QT interval prolongation, a first degree atrioventricular block or a left bundle branch block during an off-label treatment with hydroxychloroquine for COVID-19 pneumonia.

The patients, who had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and required oxygen but not intensive care, were initiated on an off-label therapy with oral hydroxychloroquine 600 mg/day. Subsequently, one patient developed a corrected QT interval prolongation of \>500ms (observed on an ECG). The second patient developed a first degree atrioventricular block after 2 days of hydroxychloroquine treatment. The third patient, who had started receiving hydroxychloroquine 5 days after the admission, was transferred to intensive care 2 days later and was then prescribed an off-label therapy with ritonavir and lopinavir for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia; this patient developed a left bundle branch block due to hydroxychloroquine on hospital day 8 \[*not all durations of treatments to reactions onsets stated*\].

Hydroxychloroquine was stopped in all the 3 patients due to their respective ADR \[*outcomes not stated*\].
